Musk Proposes to Proceed With Twitter Deal
Bloomberg Businessweek
00:00
Pfizer's COVID-19 Vaccine Is a Blockbuster
This is poised to be the best year on record for Pfizer. They're expecting over a hundred billion in revenue and more than half of that is coming from the COVID-19 vaccine and its pill. But there are a lot of questions as to whether or not any of those products can reap the same kind of success we've seen with generic competition.
Play episode from 16:00
Transcript
